Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PALISADE BIO, INC. Director's Dealing 2014

Jul 31, 2014

35274_dirs_2014-07-31_79688c68-7547-43a4-8a31-9a131216933c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2014-05-08

Reporting Person: SMITH SANDFORD D (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 25000 Direct

Footnotes

F1: Represents Restricted Stock Unit ("RSU") pursuant to the Issuer's 2010 compensation plan. The RSU's vest as follows: (i) 12,500 upon the one month anniversary of joining the Board, and (ii) 12,500 shall vest quarterly over a one year period commencing on May 8, 2014, the date Reporting Person joined the Board. If the vesting conditions are satisfied, each RSU entitles the holder to one share of the Issuer's common stock for each RSU granted.